Prevail Therapeutics' Series A Round

Prevail Therapeutics raised a round of funding on March 08, 2018.

Prevail Therapeutics was created by Regenxbio and Orbimed to focus on new biologics and gene therapies for Parkinson's disease.…

Articles about Prevail Therapeutics' Series A Round: